NQCAX
Price
$5.07
Change
+$0.06 (+1.20%)
Updated
Jun 6 closing price
Net Assets
21.54M
VIVAX
Price
$67.51
Change
+$0.65 (+0.97%)
Updated
Jun 6 closing price
Net Assets
188.77B
Interact to see
Advertisement

NQCAX vs VIVAX

Header iconNQCAX vs VIVAX Comparison
Open Charts NQCAX vs VIVAXBanner chart's image
Nuveen Large Cap Value Opportunities A
Price$5.07
Change+$0.06 (+1.20%)
VolumeN/A
Net Assets21.54M
Vanguard Value Index I
Price$67.51
Change+$0.65 (+0.97%)
VolumeN/A
Net Assets188.77B
NQCAX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NQCAX vs. VIVAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NQCAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. NQCAX (21.5M). VIVAX pays higher dividends than NQCAX: VIVAX (2.16) vs NQCAX (1.76). NQCAX was incepted earlier than VIVAX: NQCAX (18 years) vs VIVAX (33 years). NQCAX (1.61) is less costly to investors than VIVAX (0.17). NQCAX is a more actively managed with annual turnover of: 35.00 vs. VIVAX (9.00). NQCAX has a lower initial minimum investment than VIVAX: NQCAX (2500) vs VIVAX (3000). NQCAX annual gain was more profitable for investors over the last year : 7.90 vs. VIVAX (6.81). VIVAX return over 5 years is better than : 58.70 vs. NQCAX (31.83).
NQCAXVIVAXNQCAX / VIVAX
Total Expense Ratio1.000.17588%
Annual Report Gross Expense Ratio1.610.17947%
Fund Existence18 years33 years-
Gain YTD3.2991.238267%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets21.5M189B0%
Annual Yield % from dividends1.762.1681%
Returns for 1 year7.906.81116%
Returns for 3 years23.9118.51129%
Returns for 5 years31.8358.7054%
Returns for 10 years-54.70102.90-53%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.480.08
+2.35%
Arbutus Biopharma Corp
WSFS53.081.21
+2.33%
WSFS Financial Corp
MNSB18.20N/A
N/A
MainStreet Bancshares
PATH13.21-0.05
-0.38%
UiPath
FAMI1.87-0.06
-3.11%
Farmmi Inc